BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 24283207)

  • 1. Thyroid ablation with 1.1 GBq (30 mCi) iodine-131 in patients with papillary thyroid carcinoma at intermediate risk for recurrence.
    Rosário PW; Calsolari MR
    Thyroid; 2014 May; 24(5):826-31. PubMed ID: 24283207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is diagnostic iodine-131 scanning useful after total thyroid ablation for differentiated thyroid cancer?
    Cailleux AF; Baudin E; Travagli JP; Ricard M; Schlumberger M
    J Clin Endocrinol Metab; 2000 Jan; 85(1):175-8. PubMed ID: 10634383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer.
    Mazzaferri EL; Jhiang SM
    Am J Med; 1994 Nov; 97(5):418-28. PubMed ID: 7977430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Completion total thyroidectomy in children with thyroid cancer secondary to the Chernobyl accident.
    Miccoli P; Antonelli A; Spinelli C; Ferdeghini M; Fallahi P; Baschieri L
    Arch Surg; 1998 Jan; 133(1):89-93. PubMed ID: 9438766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyroglobulin determination, neck ultrasonography and iodine-131 whole-body scintigraphy in differentiated thyroid carcinoma.
    Franceschi M; Kusić Z; Franceschi D; Lukinac L; Roncević S
    J Nucl Med; 1996 Mar; 37(3):446-51. PubMed ID: 8772642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term effectiveness of low-dose radioiodune ablative treatment of thyroid remnants after thyroidectomy for differentiated thyroid cancer.
    Vermiglio F; Violi MA; Finocchiaro MD; Baldari S; Castagna MG; Moleti M; Mattina F; Pio Lo Presti V; Bonanno N; Trimarchi F
    Thyroid; 1999 Apr; 9(4):387-91. PubMed ID: 10319946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.
    Tsang RW; Brierley JD; Simpson WJ; Panzarella T; Gospodarowicz MK; Sutcliffe SB
    Cancer; 1998 Jan; 82(2):375-88. PubMed ID: 9445196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic variables of papillary and follicular thyroid carcinoma patients with lymph node metastases and without distant metastases.
    Lin JD; Liou MJ; Chao TC; Weng HF; Ho YS
    Endocr Relat Cancer; 1999 Mar; 6(1):109-15. PubMed ID: 10732793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prescribing 131Iodine based on neck uptake produces effective thyroid ablation and reduced hospital stay.
    Hodgson DC; Brierley JD; Tsang RW; Panzarella T
    Radiother Oncol; 1998 Jun; 47(3):325-30. PubMed ID: 9681898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surveillance of patients to detect recurrent thyroid carcinoma.
    Grigsby PW; Baglan K; Siegel BA
    Cancer; 1999 Feb; 85(4):945-51. PubMed ID: 10091774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole-body Tc-99m sestamibi scintigraphy in the follow-up of differentiated thyroid carcinoma.
    Almeida-Filho P; Ravizzini GC; Almeida C; Borges-Neto S
    Clin Nucl Med; 2000 Jun; 25(6):443-6. PubMed ID: 10836693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility of low doses of I-131 for thyroid ablation in postsurgical patients with thyroid carcinoma.
    Siddiqui AR; Edmondson J; Wellman HN; Hamaker RC; Lingeman RE; Park HM; Johnston CC
    Clin Nucl Med; 1981 Apr; 6(4):158-61. PubMed ID: 7214770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-suppressed thyrotropin and elevated thyroglobulin are independent predictors of recurrence in differentiated thyroid carcinoma.
    Böhm J; Kosma VM; Eskelinen M; Hollmen S; Niskanen M; Tulla H; Alhava E; Niskanen L
    Eur J Endocrinol; 1999 Nov; 141(5):460-7. PubMed ID: 10576761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radioiodine I-31 therapy in the management of thyroid cancer. A prospective study.
    Krishnamurthy GT; Blahd WH
    Cancer; 1977 Jul; 40(1):195-202. PubMed ID: 880551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroid carcinoma in children and adolescents.
    Danese D; Gardini A; Farsetti A; Sciacchitano S; Andreoli M; Pontecorvi A
    Eur J Pediatr; 1997 Mar; 156(3):190-4. PubMed ID: 9083757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gamma probe-guided resection of a lymph node metastasis with I-123 in papillary thyroid carcinoma.
    Gallowitsch HJ; Fellinger J; Mikosch P; Kresnik E; Lind P
    Clin Nucl Med; 1997 Sep; 22(9):591-2. PubMed ID: 9298290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic variables of papillary thyroid carcinomas with local invasion.
    Lin JD; Chao TC; Weng HF; Ho YS
    Endocr J; 1999 Feb; 46(1):91-8. PubMed ID: 10426572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved survival of patients with papillary thyroid cancer after surgical microdissection.
    Tisell LE; Nilsson B; Mölne J; Hansson G; Fjälling M; Jansson S; Wingren U
    World J Surg; 1996 Sep; 20(7):854-9. PubMed ID: 8678962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of primary surgery on outcome in 300 patients with pathologic tumor-node-metastasis stage III papillary thyroid carcinoma treated at one institution from 1940 through 1989.
    Hay ID; Bergstralh EJ; Grant CS; McIver B; Thompson GB; van Heerden JA; Goellner JR
    Surgery; 1999 Dec; 126(6):1173-81; discussion 1181-2. PubMed ID: 10598204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyroid cancer: some basic considerations.
    Wanebo HJ; Andrews W; Kaiser DL
    Am J Surg; 1981 Oct; 142(4):474-9. PubMed ID: 7283050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.